Real-world data shows increased reactogenicity in adults after heterologous compared to homologous prime-boost COVID-19 vaccination, March−June 2021, England

Overview of attention for article published in Eurosurveillance, July 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

news: 11 news outlets
blogs: 1 blog

policy: 1 policy source
twitter: 51 X users

Citations

dimensions_citation: 55 Dimensions

Readers on

mendeley: 61 Mendeley

Summary News Blogs Policy documents X Dimensions citations

So far, Altmetric has seen 3 policy documents that reference this research output.

Предварительные рекомендации в отношении гетерологичных схем вакцинации против COVID-19: Временное руководство, 16 декабря 2021 г.

Cited by World Health Organization on 10 Jan 2022

The World Health Organization (WHO) is the directing and coordinating authority for health within the United Nations system.

Interim recommendations for heterologous COVID-19 vaccine schedules: interim guidance, 16 December 2021

Cited by World Health Organization on 16 Dec 2021

The World Health Organization (WHO) is the directing and coordinating authority for health within the United Nations system.

Interim recommendations for heterologous COVID-19 vaccine schedules: interim guidance, 16 December 2021

Cited by World Health Organization on 01 Jan 2021

The World Health Organization (WHO) is the directing and coordinating authority for health within the United Nations system.

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.